中国中医眼科杂志
中國中醫眼科雜誌
중국중의안과잡지
JOURNAL OF TRADITIONAL CHINESE OPHTHALMOLOGY
2015年
2期
114-117
,共4页
董如娇%陈芳%赵霞%李冬育%董明霞
董如嬌%陳芳%趙霞%李鼕育%董明霞
동여교%진방%조하%리동육%동명하
全视网膜激光治疗%糖尿病视网膜病变%羟苯磺酸钙%芪明颗粒%疗效
全視網膜激光治療%糖尿病視網膜病變%羥苯磺痠鈣%芪明顆粒%療效
전시망막격광치료%당뇨병시망막병변%간분광산개%기명과립%료효
pan-rephotocoagulation%diabetic retinopathy%calcium dobesilate%Qiming granule%effect
目的:探讨全视网膜激光(PRP)联合口服药物对于糖尿病视网膜病变(DR)中的治疗作用。方法增殖前期及增殖期有全视网膜光凝适应症的糖尿病视网膜病变患者158例(267只眼),分为4组。单纯PRP组(A组)38例(62只眼),予单纯PRP治疗;芪明颗粒+PRP组(B组)42例(72只眼),予口服芪明颗粒联合PRP;羟苯磺酸钙+PRP组(C组)40例(69只眼),予口服羟苯磺酸钙联合PRP;芪明颗粒+羟苯磺酸钙+PRP组(D组)38例(64只眼),口服芪明颗粒、羟苯磺酸钙联合PRP治疗。治疗前及治疗3个月后进行最佳矫正视力、眼底照相、荧光素眼底血管造影(FFA)、光学相干断层扫描(OCT)检查,评价治疗效果。结果 A组治疗后视力有统计学意义的下降(t=2.723,P=0.008),其余3组视力无明显下降(P>0.05)。A、B、C、D组的视力有效率分别为64.5%、81.9%、82.6%、89.1%(χ2=12.922,P=0.005),FFA有效率为69.4%、86.1%、85.5%、89.1%(χ2=10.528,P=0.015),黄斑水肿有效率41.2%、50.0%、45.5%、57.1%(χ2=1.092,P=0.779)。结论 PRP联合羟苯磺酸钙或芪明颗粒可以减轻光凝导致的视力下降,并改善患眼视网膜的缺氧状态,PRP同时联合羟苯磺酸钙及芪明颗粒的效果相对更好。
目的:探討全視網膜激光(PRP)聯閤口服藥物對于糖尿病視網膜病變(DR)中的治療作用。方法增殖前期及增殖期有全視網膜光凝適應癥的糖尿病視網膜病變患者158例(267隻眼),分為4組。單純PRP組(A組)38例(62隻眼),予單純PRP治療;芪明顆粒+PRP組(B組)42例(72隻眼),予口服芪明顆粒聯閤PRP;羥苯磺痠鈣+PRP組(C組)40例(69隻眼),予口服羥苯磺痠鈣聯閤PRP;芪明顆粒+羥苯磺痠鈣+PRP組(D組)38例(64隻眼),口服芪明顆粒、羥苯磺痠鈣聯閤PRP治療。治療前及治療3箇月後進行最佳矯正視力、眼底照相、熒光素眼底血管造影(FFA)、光學相榦斷層掃描(OCT)檢查,評價治療效果。結果 A組治療後視力有統計學意義的下降(t=2.723,P=0.008),其餘3組視力無明顯下降(P>0.05)。A、B、C、D組的視力有效率分彆為64.5%、81.9%、82.6%、89.1%(χ2=12.922,P=0.005),FFA有效率為69.4%、86.1%、85.5%、89.1%(χ2=10.528,P=0.015),黃斑水腫有效率41.2%、50.0%、45.5%、57.1%(χ2=1.092,P=0.779)。結論 PRP聯閤羥苯磺痠鈣或芪明顆粒可以減輕光凝導緻的視力下降,併改善患眼視網膜的缺氧狀態,PRP同時聯閤羥苯磺痠鈣及芪明顆粒的效果相對更好。
목적:탐토전시망막격광(PRP)연합구복약물대우당뇨병시망막병변(DR)중적치료작용。방법증식전기급증식기유전시망막광응괄응증적당뇨병시망막병변환자158례(267지안),분위4조。단순PRP조(A조)38례(62지안),여단순PRP치료;기명과립+PRP조(B조)42례(72지안),여구복기명과립연합PRP;간분광산개+PRP조(C조)40례(69지안),여구복간분광산개연합PRP;기명과립+간분광산개+PRP조(D조)38례(64지안),구복기명과립、간분광산개연합PRP치료。치료전급치료3개월후진행최가교정시력、안저조상、형광소안저혈관조영(FFA)、광학상간단층소묘(OCT)검사,평개치료효과。결과 A조치료후시력유통계학의의적하강(t=2.723,P=0.008),기여3조시력무명현하강(P>0.05)。A、B、C、D조적시력유효솔분별위64.5%、81.9%、82.6%、89.1%(χ2=12.922,P=0.005),FFA유효솔위69.4%、86.1%、85.5%、89.1%(χ2=10.528,P=0.015),황반수종유효솔41.2%、50.0%、45.5%、57.1%(χ2=1.092,P=0.779)。결론 PRP연합간분광산개혹기명과립가이감경광응도치적시력하강,병개선환안시망막적결양상태,PRP동시연합간분광산개급기명과립적효과상대경호。
OBJECTIVE To investigate the pan-rephotocoagulation (PRP) combined with medication for the treatment for diabetic retinopathy (DR). METHODS Proliferation and pre-proliferation diabetic retinopathy with indications of PRP 158 cases (267 eyes), were divided into four groups. PRP group 38 patients (group A, 62 eyes), by simply PRP therapy;Qiming granule+PRP group 42 patients (group B, 72 eyes), by combined oral Qiming gran-ule with PRP;Dobesilate Ca+PRP group of 40 patients (group C, 69 eyes), by combined oral calcium Dobesilate with PRP;Qiming granule+Dobesilate calcium+PRP group of 38 patients (group D, 64 eyes), by oral Qi Ming particles Dobesilate calcium combined PRP therapy. The effect of treatment was evaluated by the best corrected vi-sual acuity, fundus photography, FFA, OCT examination before treatment and three months after treatment. RE-SULTS Compared with the other 3 groups , after treat-ment the decline of visual acuity of group A had statis-tical significance (t=2.723,P=0.008). The effective rate of visual acuity of group A,B,C,D was 64.5%, 81.9%, 82.6%, 89.1%respectively (χ2=12.922,P=0.005). Effec-tive rate of FFA was 69.4%, 86.1%, 85.5%, 89.1%(χ2=10.528,P=0.015), and effective rate for macular edema was 41.2%, 50.0%, 45.5%, 57.1% (χ2=1.092,P=0.779). CONCLUSIONS PRP combination therapy was not only ef-fective in promoting regression of neovascularization, but also could improve DR-induced vision loss in patients with PRP.